Authors:
OSHAUGHNESSY JA
COWAN KH
NIENHUIS AW
MCDONAGH KT
SORRENTINO BP
DUNBAR CE
CHIANG YW
WILSON W
GOLDSPIEL B
KOHLER D
COTTLERFOX M
LEITMAN S
GOTTESMAN M
PASTAN I
DENICOFF A
NOONE M
GRESS R
Citation: Ja. Oshaughnessy et al., RETROVIRAL-MEDIATED TRANSFER OF THE HUMAN MULTIDRUG-RESISTANCE GENE (MDR-1) INTO HEMATOPOIETIC STEM-CELLS DURING AUTOLOGOUS TRANSPLANTATIONAFTER INTENSIVE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER, Human gene therapy, 5(7), 1994, pp. 891-911
Authors:
OSHAUGHNESSY JA
DENICOFF AM
VENZON DJ
DANFORTH D
PIERCE LJ
FRAME JN
BASTIAN A
GHOSH B
GOLDSPIEL B
MILLER L
DORR FA
KEEGAN P
BENBARUCH N
MROSE H
NOONE M
COWAN KH
Citation: Ja. Oshaughnessy et al., A DOSE INTENSITY STUDY OF FLAC (5-FLUOROURACIL, LEUCOVORIN, DOXORUBICIN, CYCLOPHOSPHAMIDE) CHEMOTHERAPY AND ESCHERICHIA-COLI-DERIVED GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN ADVANCED BREAST-CANCER PATIENTS, Annals of oncology, 5(8), 1994, pp. 709-716
Citation: Jm. Gudas et al., CELL-CYCLE DEPENDENT EXPRESSION OF MDM-2 IN NORMAL AND IMMORTALIZED HUMAN BREAST EPITHELIAL-CELLS, Journal of cellular biochemistry, 1994, pp. 168-168
Authors:
PIERCE LJ
MERINO MJ
DANGELO T
BARKER EA
GILBERT L
COWAN KH
STEINBERG SM
GLATSTEIN E
Citation: Lj. Pierce et al., IS C-ERB B-2 A PREDICTOR FOR RECURRENT DISEASE IN EARLY-STAGE BREAST-CANCER, International journal of radiation oncology, biology, physics, 28(2), 1994, pp. 395-403
Authors:
MCAFEE JG
CARRASQUILLO JA
CAMERA L
OSHAUGHNESSY JA
COWAN KH
NEUMANN RD
Citation: Jg. Mcafee et al., CHANGES IN SKELETAL IMAGES INDUCED BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN PATIENTS WITH LOCALLY ADVANCED AND METASTATIC BREAST-CANCER, The Journal of nuclear medicine, 35(5), 1994, pp. 160000089-160000089
Citation: Ja. Oshaughnessy et al., COMBINATION PACLITAXEL (TAXOL) AND DOXORUBICIN THERAPY FOR METASTATICBREAST-CANCER, Seminars in oncology, 21(5), 1994, pp. 19-23
Authors:
MORROW CS
NAKAGAWA M
GOLDSMITH ME
MADDEN MJ
COWAN KH
Citation: Cs. Morrow et al., REVERSIBLE TRANSCRIPTIONAL ACTIVATION OF MDR1 BY SODIUM-BUTYRATE TREATMENT OF HUMAN COLON-CANCER CELLS, The Journal of biological chemistry, 269(14), 1994, pp. 10739-10746
Authors:
DIXON KH
LANPHER BC
CHIU J
KELLEY K
COWAN KH
Citation: Kh. Dixon et al., A NOVEL CDNA RESTORES REDUCED FOLATE CARRIER ACTIVITY AND METHOTREXATE SENSITIVITY TO TRANSPORT DEFICIENT CELLS, The Journal of biological chemistry, 269(1), 1994, pp. 17-20
Authors:
SCHNEIDER E
HORTON JK
YANG CH
NAKAGAWA M
COWAN KH
Citation: E. Schneider et al., MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN GENE OVEREXPRESSION AND REDUCED DRUG-SENSITIVITY OF TOPOISOMERASE-II IN A HUMAN BREAST-CARCINOMA MCF7 CELL-LINE SELECTED FOR ETOPOSIDE RESISTANCE, Cancer research, 54(1), 1994, pp. 152-158
Authors:
OSHAUGHNESSY JA
COWAN KH
WILSON W
BRYANT G
GOLDSPIEL B
GRESS R
NIENHUIS AW
DUNBAR C
SORRENTINO B
STEWART FM
MOEN R
FOX M
LEITMAN S
Citation: Ja. Oshaughnessy et al., PILOT-STUDY OF HIGH-DOSE ICE (IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE) CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) WITH NEOR-TRANSDUCED BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH METASTATIC BREAST-CANCER, Human gene therapy, 4(3), 1993, pp. 331-354
Authors:
YOKOZAKI H
BUDILLON A
CLAIR T
KELLEY K
COWAN KH
ROHLFF C
GLAZER RI
CHOCHUNG YS
Citation: H. Yokozaki et al., 8-CHLOROADENOSINE 3',5'-MONOPHOSPHATE AS A NOVEL MODULATOR OF MULTIDRUG-RESISTANCE, International journal of oncology, 3(3), 1993, pp. 423-430
Authors:
SAVARESE DMF
DENICOFF AM
BERG SL
HILLIG M
BAKER SP
OSHAUGHNESSY JA
CHOW C
OTTERSON GA
BALIS FM
POPLACK DG
COWAN KH
Citation: Dmf. Savarese et al., PHASE-I STUDY OF HIGH-DOSE PIROXANTRONE WITH GRANULOCYTE-COLONY-STIMULATING FACTOR, Journal of clinical oncology, 11(9), 1993, pp. 1795-1803
Authors:
BENBARUCH N
DENICOFF AM
GOLDSPIEL BR
OSHAUGHNESSY JA
COWAN KH
Citation: N. Benbaruch et al., PHASE-II STUDY OF FAZARABINE (NSC-281272) IN PATIENTS WITH METASTATICCOLON-CANCER, Investigational new drugs, 11(1), 1993, pp. 71-74
Citation: Ja. Oshaughnessy et Kh. Cowan, DOSE-INTENSIVE THERAPY FOR BREAST-CANCER, JAMA, the journal of the American Medical Association, 270(17), 1993, pp. 2089-2092
Authors:
CHUNG KN
SAIKAWA Y
PAIK TH
DIXON KH
MULLIGAN T
COWAN KH
ELWOOD PC
Citation: Kn. Chung et al., STABLE TRANSFECTANTS OF HUMAN MCF-7 BREAST-CANCER CELLS WITH INCREASED LEVELS OF THE HUMAN FOLATE RECEPTOR EXHIBIT AN INCREASED SENSITIVITYTO ANTIFOLATES, The Journal of clinical investigation, 91(4), 1993, pp. 1289-1294
Authors:
BERG SL
SAVARESE DMF
BALIS FM
DENICOFF AM
HILLIG M
OSHAUGHNESSY JA
POPLACK DG
COWAN KH
Citation: Sl. Berg et al., PHARMACOKINETICS OF PIROXANTRONE IN A PHASE-I TRIAL OF PIROXANTRONE AND GRANULOCYTE-COLONY-STIMULATING FACTOR, Cancer research, 53(11), 1993, pp. 2587-2590
Citation: Ja. Moscow et al., DECREASED MELPHALAN ACCUMULATION IN A HUMAN BREAST-CANCER CELL-LINE SELECTED FOR RESISTANCE TO MELPHALAN, British Journal of Cancer, 68(4), 1993, pp. 732-737
Authors:
DUNBAR CE
OSHAUGHNESSY JA
COTTLERFOX M
CARTER CS
DOREN S
COWAN KH
LEITMAN SF
WILSON W
YOUNG NS
NIENHUIS AW
Citation: Ce. Dunbar et al., TRANSPLANTATION OF RETROVIRALLY-MARKED CD34-MARROW AND PERIPHERAL-BLOOD CELLS IN PATIENTS WITH MULTIPLE-MYELOMA OR BREAST-CANCER( BONE), Blood, 82(10), 1993, pp. 10000217-10000217